WASHINGTON, Nov. 3 /PRNewswire-USNewswire/ -- The American Society of Hematology, the world's largest professional society of blood specialists, welcomes five new officers to its Executive Committee, the governing body of the organization. The officers will begin serving their terms in January 2010.
Armand Keating, MD, will serve a one-year term as vice-president, followed by successive terms as president-elect and president. New councillors Marilyn J. Telen, MD, and Kenneth C. Anderson, MD, will serve four-year terms, and Mohandas Narla, DSc, will serve as councillor for a one-year term. These individuals are well-respected hematologists and active members of the Society.
Dr. Keating is Professor of Medicine and Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation, University of Toronto, and Director, Cell Therapy Program, Princess Margaret Hospital, Toronto. His clinical and research interests focus on anti-cancer cell therapy, blood and marrow transplantation, leukemia, lymphoma, and cell-based tissue regeneration. He has conducted laboratory, translational, and clinical research in cell therapy, normal and leukemic hematopoiesis, and the biology and clinical application of mesenchymal stromal cells.
Dr. Telen, Wellcome Professor of Medicine and Chief, Division of Hematology, Duke University Medical Center, is recognized as an expert in the biochemistry and molecular genetics of blood group antigens and the pathophysiological mechanisms of vaso-occlusion in sickle cell disease. She is the director of the Duke Comprehensive Sickle Cell Center.
Dr. Anderson, Kraft Family Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute (DFCI), is Chief of the Division of Hematologic Neoplasia, Director of the Lipper Myeloma Center and Lebow Institute for Myeloma Therapeutics, and Vice Chair of the Joint Program in Transfusion Medicine at DFCI. His area of research is nove
|SOURCE American Society of Hematology|
Copyright©2009 PR Newswire.
All rights reserved